期刊文献+

食蟹猴年龄相关的运动功能减退及其与纹状体多巴胺转运体的关系 被引量:2

Age-related decline in motor behavior and its association with striatal dopamine transporter in cynomolgus monkeys
原文传递
导出
摘要 目的研究食蟹猴老化过程中运动行为和脑内纹状体多巴胺系统功能变化及两者之间的相关关系。方法选取4岁、10岁和15岁3个年龄组的健康食蟹猴共29只,利用计算机化的网络摄像头视频检测系统和行为分析软件连续采集和分析每个动物8h随意运动活动总量,各年龄组分别选取4只动物用多巴胺转运体(DAT)配体99mTc-TRODAT-1结合单光子发射体层摄影术(SPECT)显像观察脑内纹状体多巴胺转运体放射性摄取率的变化。结果在4岁、10岁和15岁年龄组,8h随意运动活动总量(×106)分别为5·00±1·93,3·28±1·02,2·79±0·67,在10岁和15岁较之4随年龄组分别降低了34·50%和55·71%(P<0·05,P<0·01),但此两个年龄组运动活动总量无显著差异(P>0·05);纹状体99mTc-TRODAT-1放射性摄取率分别为2·98±0·08,2·56±0·12和2·27±0·35,10岁和15岁较之4随年龄组分别降低了14·00%和25·60%,但仅4岁与15岁年龄组存在显著相关关系(P<0·01)。二者均随着年龄的增长呈逐渐减低的趋势,直线回归分析显示两者分别与年龄呈负相关关系(r=-0·57,P=0·001;r=-0·86,P<0·01)。8h随意运动活动总量与纹状体99mTc-TRODAT-1放射性摄取率呈显著的正相关关系(r=0·70,P<0·05)。结论正常食蟹猴老化过程中,脑内多巴胺神经系统功能的减退伴随着运动行为的减少,两者之间的相关关系进一步佐证了运动功能的减退可能是由于纹状体内多巴胺神经元功能减退所致。 Objective To investigate the age-related alterations of motor behavior and striatal dopamine transporter (DAT) as well as their correlation in normal cynomolgus monkeys. Methods A total of 29 healthy cynomolgus monkeys rangingfrom 3.5 - 15.5 years old were used. The 8-hour quantitative measurements of random movement were evaluated utilizing a computerized webcam monitoring system, moreover, in vivo striatal DAT level was determined by 99m^Tc-TRODAT-1 SPECT imaging. Results It was shown that the 8-hour total counts (million) were 5.00 ± 1.93,3. 28 ±1.02,2. 79 ±0. 67 in 4-, 10- and 15- year old groups, and a significant decrease of 34. 50% and 55.71% activity counts was found in the 10- and 15-year old group compared to the 4-year old group, respectively ( P 〈 0. 05) , but the difference between the latter two groups was not statistically different (P 〉0. 05 ). The average specific uptake values were 2. 98 ±0. 08 (4-year age), 2. 56 ±0. 12 ( 10-year age) and 2. 27 ±0. 35 ( 15-year age) respectively, indicating a respectivel4. 00% and 25.60% decrease in the uptake rate of 99m^Tc-TRODAT-1 in 10- and 15-year old animals, respectively, as compared to the 4-year old animals. Comparison of inter-group (ANOVA) analysis displayed a significant difference ( P 〈 0. 05 ) only between 4- and 15-year old groups ( P 〈 0. 01 ). A significant decline in 8 hours home cage activity counts and in vivo striatal DAT uptake was found with aging,respectively (r =- 0. 57, P = 0. 001 ; r = -0. 86, P 〈 0. 01 ). A statistical correlativity between the age- related decrease of in vivo striatal DAT uptake ratio and the decline of 8-hour activity counts were demonstrated ( r = 0.70, P 〈 0. 05). Conclusion In normal cynomolgus monkeys, the age-related decline of striatal dopaminergic nerve terminals is associated with age-related decline of motor behavior, supporting the putative hypothesis that the decline of motor function is resulted from deterioration of nigrostriatal dopaminergic system.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2006年第11期776-781,共6页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(30460141 30430280) 国家科技部资助项目(2002BA711A07-04) 国家973重点基础研究发展计划资助项目(2006CB500701)
关键词 运动机能减退 纹状体 膜转运蛋白质类 神经组织蛋白质类 衰老 成束猴类 Hypokinesia Corpus striatum Membrane transport proteins Nerve tissueproteins Aging Macaca fascicularis
  • 相关文献

参考文献1

二级参考文献1

共引文献9

同被引文献21

  • 1Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xi'an, and Shanghai. Lancet, 2005, 365:595-597.
  • 2Emborg ME, Ma SY, Mufson EJ, et al. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol, 1998, 401:253-265.
  • 3Levy G, Louis ED, Cote L, et al. Contribution of aging to the severity of different motor signs in Parkinson disease. Arch Neurol, 2005, 62:467-472.
  • 4Thai DR, Del Trediei K, Braak H. Neurodegeneration in normal brain aging and disease. Sci Aging Knowledge Environ, 2004, 23:26.
  • 5Biskup S, Moore DJ. Detrimental deletions : mitochondria, aging and Parkinson's disease. Bioessays, 2006, 28:963-967.
  • 6Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Move Dis, 2003, 18 (Suppl 7) :S43-S51.
  • 7Sotnikova TD, Beaulieu JM, Gainetdinov RR, et al. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. CNS Neurol Disord Drug Targets, 2006, 5:45-56.
  • 8Storch A, Ludolph AC, Schwarz J. Dopamine transporter: involvement in selective dopaminergic neurotoxieity and degeneration. J Neural Transm, 2004, 111:1267-1286.
  • 9Sidhu A, Wersinger C, Vernier P. Alpha-Synuclein regulation of the dopaminergic transporter:a possible role in the pathogenesis of Parkinson's disease. FEBS Lett, 2004, 565:1-5.
  • 10Wersinger C, Sidhu A. Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett, 2003, 340: 189-192.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部